EQT Private Equity to acquire Zeus, a global leader in advanced polymer components used in life-saving medical procedures Post author: Post published:December 18, 2023 Post category:uncategorized Post Content You Might Also Like MaxCyte® acquires SeQure Dx to broaden cell engineering offerings with on-target and off-target editing assessments February 6, 2025 Breakthrough gene therapy offers hope for Duchenne muscular dystrophy July 18, 2024 Earlier diabetes diagnosis linked to dementia risk November 20, 2024
MaxCyte® acquires SeQure Dx to broaden cell engineering offerings with on-target and off-target editing assessments February 6, 2025